Biomit Inc. Expands in Europe and the United States

Basel, Switzerland (PROTEXT) - Biomit Inc., a strategic e-clinical research partner for the biopharmaceutical industry, israpidly expanding to establish offices throughout Europe as wellas integrated worldwide representation. Today marks the officialopening of its office in Bordeaux, France, which will coordinateon-line, electronic clinical research trials in France and Spain.At the same time, SiberHegner, a leading international marketingand services group with a 136-year history, has signed torepresent Biomit in the United States. Heading the Bordeaux office is Brigitte Sarrazin, MD, PhD, whohas extensive clinical research experience in both projectmanagement and marketing. Most recently, Dr. Sarrazin was medicaldirector at the Laboratoires Pierre Fabre in France. "Exceptional quality of clinical data, as well as transparencyand accelerated access to medical knowledge are increasinglycritical for our customers. Biomit's very attractive andinnovative internet-based tool for electronic data capturetechnology substantially improves how clinical trials aremanaged," said Dr. Sarrazin. "I'm honored to join Biomit's highlyexperienced team of clinical research professionals." SiberHegner North America, Inc. is located in Baltimore,Maryland, and its marketing focus includes innovative technologyproducts and valuable pharmaceuticals, as well as consumer goodsand other products. "With Biomit, US pharma and biotech companies have a strategicclinical research trial management partner with extensiveexperience in all phases of clinical trials conducted in Europe.SiberHegner, with its experienced sales professionals, is anideal partner who will extend our marketing activities andestablish a strong and powerful cooperation to make our servicesavailable to US companies." said Derek Brandt, co-founder and CEOof Biomit. ABOUT BIOMIT Founded in September 2000, Biomit is an innovative clinicalresearch organization (CRO) that combines the latest electronicdata capture (EDC) technology with high scientific expertise inproject management to ensure professional service when conductingclinical trials and to accelerate the development and delivery ofnew pharmaceutical and biotechnological products. (continued) With an Internet-based tool that provides an innovative,flexible and fast solution for the execution of e-clinicaltrials, Biomit offers substantial quality improvement andsignificant cost reduction in support of any and all aspects ofphase I-IV clinical trials within Europe, in a variety oftherapeutic areas. Locally established in Central Europe withheadquarters in Basel, Switzerland, Biomit is one of the firstEuropean-based clinical research organizations to conduct e-clinical trials. Additional information about Biomit is availableat http:// www.biomit.com.

ots Originaltext: Biomit Inc. Im Internet recherchierbar:http://www.presseportal.de For press inquiries, please contact:Dr. Zuzana Dobbie Biomit Inc. St. Alban Anlage 44 CH-4052 Basel,Switzerland Tel: +41 (0)61 206 12 12 Email: info@biomit.ch Website: www.biomit.com Other information: Bordeaux, France: Dr.Brigitte Sarrazin Biomit France SAS Parc Tertiaire Innolin 8, ruedu Golf 33700 Merignac - France Tel: +33 557 291 700 Baltimore,USA: Jean Chambers Biomit Inc. c/o SiberHegner North America 300East Lombard Street, Suite 630 Baltimore, MD 21202 - USA Tel.: +1410 385 1666 Fax: +1 410 385 1266 Email:jean.chambers@siberhegner.com Biomit Inc., St. Alban Anlage 44,CH-4052 Basel, Switzerland Tel.: +41 (0) 61 206 12 12 / Fax: +41(0) 61 206 12 22

Subscribers please note that material bearing the slug"PROTEXT" is not part of CTK's news service and is not to bepublished under the "CTK" slug. Protext is a commercial serviceproviding distribution of press releases from clients, who areidentified in the text of Protext reports and who bear fullresponsibility for their contents.

PROTEXT